- More tensions are rising in the takeover battle for Allergan (NYSE:AGN), as Bill Ackman and Valeant (VRX) say CEO David Pyott tried to discredit Valeant as it was making a hostile takeover bid.
- The court filing made late on Monday in California, accuses Pyott of providing false and misleading information about Valeant to investors, failing to disclose Allergan CFO Jeff Edward's resignation in a timely manner, and ignoring outside advisors' input when he falsely called Valeant's account "opaque" and "problematic."